AGL EBITDA Growth
Agilon Health · EBITDA Growth
AGL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported20.54%period ending
AGL TTM EBITDA YoY % (-456.39% → 20.54%)
Year-over-year change
High-resolution chart · PNG
AGL ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 20.5419% | |
| -53.629% | |
| -69.0581% | |
| -3.3829% | |
| -61.8737% | |
| -32.6313% | |
| -33.4104% | |
| -376.0118% | |
| -160.5436% | |
| -113.1897% | |
| -87.1396% | |
| 35.1734% | |
| 27.4685% | |
| 78.8966% | |
| 77.2287% | |
| 75.328% | |
| 71.6003% | |
| -724.6815% | |
| -456.388% |